Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reverse cardio-oncology: Exploring the effects of cardiovascular disease on cancer pathogenesis
Graeme J. Koelwyn, Joseph Pierre Aboumsallem, Kathryn J. Moore, et al.
Journal of Molecular and Cellular Cardiology (2021) Vol. 163, pp. 1-8
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Small Extracellular Vesicles From Infarcted and Failing Heart Accelerate Tumor Growth
Tal Caller, Itai Rotem, Olga Shaihov–Teper, et al.
Circulation (2024) Vol. 149, Iss. 22, pp. 1729-1748
Closed Access | Times Cited: 18
Long-term cardiac MRI follow up of MANTICORE (Multidisciplinary Approach to Novel Therapies in Cardio-Oncology REsearch)
Dina Labib, Mark J. Haykowsky, Emer Sonnex, et al.
Cardio-Oncology (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 2
Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer
Anja Karlstaedt, Javid J. Moslehi, Rudolf A. de Boer
Nature Reviews Cardiology (2022) Vol. 19, Iss. 6, pp. 414-425
Open Access | Times Cited: 56
Priorities in Cardio-Oncology Basic and Translational Science
Fadi N. Salloum, Carlo G. Tocchetti, Pietro Ameri, et al.
JACC CardioOncology (2023) Vol. 5, Iss. 6, pp. 715-731
Open Access | Times Cited: 23
Complications and comorbidities associated with antineoplastic chemotherapy: Rethinking drug design and delivery for anticancer therapy
Xiaoman Mao, Shuang Wu, Dandan Huang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2901-2926
Open Access | Times Cited: 8
Clonal haematopoiesis of indeterminate potential: associations with heart failure incidence, clinical parameters and biomarkers
Canxia Shi, Joseph Pierre Aboumsallem, Navin Suthahar, et al.
European Journal of Heart Failure (2022) Vol. 25, Iss. 1, pp. 4-13
Open Access | Times Cited: 34
Targeting DNA damage response in cardiovascular diseases: from pathophysiology to therapeutic implications
Lin Wu, James R. Sowers, Yingmei Zhang, et al.
Cardiovascular Research (2022) Vol. 119, Iss. 3, pp. 691-709
Closed Access | Times Cited: 33
Multifactorial Diseases of the Heart, Kidneys, Lungs, and Liver and Incident Cancer: Epidemiology and Shared Mechanisms
Canxia Shi, Sanne de Wit, Emina Učambarlić, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 729-729
Open Access | Times Cited: 20
Temporal trends in the incidence of malignancy in heart failure: a nationwide Danish study
Jonas Bruhn, Morten Malmborg, Caroline Hartwell Garred, et al.
European Heart Journal (2023) Vol. 44, Iss. 13, pp. 1124-1132
Closed Access | Times Cited: 14
The role of cholesterol metabolism in tumor therapy, from bench to bed
Wenhao Xia, Hao Wang, Xiaozhu Zhou, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Association between heart failure and the incidence of cancer: a systematic review and meta-analysis
Vikash Jaiswal, Song Peng Ang, Vibhor Agrawal, et al.
European Heart Journal Open (2023) Vol. 3, Iss. 5
Open Access | Times Cited: 14
CVD phenotyping in oncologic disorders: cardio-miRNAs as a potential target to improve individual outcomes in revers cardio-oncology
Ming Yang, Tiepeng Li, Shujin Guo, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Risk of Post‐Transplant Malignancy After Isolated Heart Transplant Among Adult Patients With Congenital Heart Disease
Orly Leiva, Stephanie Golob, Alex Reyentovich, et al.
Clinical Transplantation (2025) Vol. 39, Iss. 1
Closed Access
An update on the European Society of Cardiology Council of Cardio-Oncology
Teresa López‐Fernández, Peter van der Meer, Alexander R. Lyon
European Heart Journal (2025)
Closed Access
Update on preclinical models of cancer therapy‐related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio‐Oncology, and the ESC Working Group on Cellular Biology of the Heart
Alessandra Ghigo, Pietro Ameri, Aarti Asnani, et al.
European Journal of Heart Failure (2025)
Open Access
Evolving perspectives in reverse cardio-oncology: A review of current status, pathophysiological insights, and future directives
Shahzeb Imran, Medha Sridhar Rao, Muhammad Hamza Shah, et al.
Current Problems in Cardiology (2024) Vol. 49, Iss. 3, pp. 102389-102389
Open Access | Times Cited: 4
Cancer and Cardiovascular Disease: The Conjoined Twins
Mohammad Zmaili, Jafar Alzubi, Motasem Alkhayyat, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1450-1450
Open Access | Times Cited: 4
Atherosclerosis and the Bidirectional Relationship between Cancer and Cardiovascular Disease: From Bench to Bedside—Part 1
Giuseppina Gallucci, Fabio Maria Turazza, Alessandro Inno, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4232-4232
Open Access | Times Cited: 4
Cross-Disease Communication in Cardiovascular Disease and Cancer
Richard Von Itter, Kathryn J. Moore
JACC CardioOncology (2024) Vol. 6, Iss. 1, pp. 67-70
Open Access | Times Cited: 3
Extracellular Vesicles: Bridging the Heart and Tumor in Reverse Cardio-Oncology
Alexandra Newman, Richard Von Itter, Kathryn J. Moore
Circulation (2024) Vol. 149, Iss. 22, pp. 1749-1751
Closed Access | Times Cited: 3
A novel nomogram for predicting cardiometabolic diseases from modifiable risks in middle-aged adults-implication for health education
Chia‐Hao Chang, Ming‐Shyan Lin, Yu‐Chih Lin, et al.
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 2
The Conundrum of Cancer-Associated Thrombosis: Lesson Learned from Two Intriguing Cases and Literature Review
Simona Laurino, Sabino Russi, Ludmila Carmen Omer, et al.
Diseases (2024) Vol. 12, Iss. 3, pp. 47-47
Open Access | Times Cited: 2
Enhancing patient outcomes: Integrating electronic cardiology consultation in primary care for cancer patients
Sergio Cinza‐Sanjurjo, Pilar Mazón‐Ramos, Daniel Rey‐Aldana, et al.
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 8
Open Access | Times Cited: 2
Therapy-naïve malignancy causes cardiovascular disease: a state-of-the-art cardio-oncology perspective
Leslie M. Ogilvie, Bridget Coyle‐Asbil, Keith R. Brunt, et al.
AJP Heart and Circulatory Physiology (2024) Vol. 326, Iss. 6, pp. H1515-H1537
Closed Access | Times Cited: 2
Circular RNAs at the intersection of cancer and heart disease: potential therapeutic targets in cardio-oncology
Dimyana Neufeldt, Sarah Cushman, Christian Bär, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 7, pp. 1495-1508
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top